Susha Cheriyedath

Feature Writer

B.Sc Chemistry, M.Sc. Biochemistry

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

Passionate about health and nutrition, Susha is interested in various diet types, such as veganism, and their impact on the body and metabolism. She remains dedicated to staying current with the latest developments in the medical and health science fields. In her leisure time, she engages in gardening, cooking/baking, and sketching/painting. When not immersed in work, she can often be found tending to her garden (weather permitting) or engrossed in her sketching and painting projects.

See less

Articles from Susha

Mass testing is not a ‘silver bullet’ for managing SARS-CoV-2 transmission, say researchers

A team of researchers from various institutions in France recently used a mathematical model to assess the impact of mass testing in controlling the SARS-CoV-2 epidemic. They evaluated the potential impact of mass testing campaigns in an epidemic rebound scenario at the end of the ongoing lockdown in Metropolitan France.

16 Dec 2020

Autoimmune condition biomarkers promote SARS-CoV-2 viral entry, study finds

Researchers have reported that the autoimmune PTPN2 risk variant rs1893217 promotes the expression of the SARS-CoV-2 receptor, ACE2, and thus promotes cellular entry, which is mediated by SARS-CoV-2 spike S protein.

16 Dec 2020

Research shows fitness suffered in most individuals during COVID-19

Researchers from the University of Texas, San Antonio and UT-Health Sciences, Texas, recently attempted to fill this knowledge gap by addressing how the COVID-19 pandemic and related stay-at-home orders are changing the daily habits of individuals.

14 Dec 2020

Could anterior nasal swabs be an effective alternative for SARS-CoV-2 testing?

Researchers from various institutions in Germany and Switzerland recently performed a prospective diagnostic accuracy study, in which they compared professional-collected anterior nasal swabs to nasopharyngeal swabs, using WHO-listed SARS-CoV-2 Ag-RDT (STANDARD Q COVID-19 Ag Test, SD Biosensor) test kits.

10 Dec 2020

Saliva samples may be reliable alternative to nasal swabs for SARS-CoV-2 testing

A team of researchers from various institutes in Switzerland report how saliva samples may be a strong alternative to nasal swaps in PCR-related SARS-CoV-2 testing.

8 Dec 2020

Nearly 70% of diabetic patients in Indonesia experience disease management difficulties, study finds

Researchers from the Fatmawati General Hospital, Indonesia, recently determined the difficulties in diabetes management and how it impacts diabetes morbidity in Indonesia during the COVID-19 pandemic.

7 Dec 2020

COVID-19 genetic risk variants impact diverse immune cell types and severe disease manifestations

A team of researchers from UK and US used the DICE database and 3D cis-interactome maps to generate a list of target genes and immune cell types that are most affected by the genetic variants associated with COVID-19 severity.

7 Dec 2020

Low testosterone can increase risk of severe COVID-19 in males

Researchers from the USA and Saudi Arabia describe the direct correlation between testosterone levels, inflammatory cytokines, disease progression, and worse outcomes in male COVID-19 patients.

4 Dec 2020

SARS-CoV-2 enters the CNS via multiple routes and causes various neurological disorders

The COVID-19 pandemic has led to millions of deaths across the globe. The causative agent of this disease is the novel coronavirus, SARS-CoV-2.

3 Dec 2020

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

In an article published in the journal Virus Research, a team of researchers from various US institutions discussed their study that evaluated the antiviral activity of PTC299 against a group of RNA viruses in vitro.

1 Dec 2020